Lung cancer is emerging as a prime cause of cancer deaths in under developed countries. Extremely high mortality rates are due to non-awareness of health regarding issues like smoking, radiation exposure and air pollution along with specific occupational toxicity leading to great incidence of lung malignancy. Biomarker is defined as any type of specific parameter which can assess any kind of undergoing abnormality and unnatural happening in living beings. Recent proteomic methodologies have been providing worthwhile advancements in indication, identification and control of disease. In this study, comprehensive set of modern proteomic methodologies have been implied to identify the specific role of lung cancer serum proteins which may prove as a standard criteria for evaluation of disease compared to other types of diseases. 100 lung cancer patients along with 50 age matched healthy persons participated in study fulfilling all ethical guidelines. SDS-PAGE, two dimensional gel electrophoresis coupled with in-gel digestion, Maldi-Tof-Tof technique, electro-elution of identified proteins and immune-detection by western blotting have been used in present study to identify and elaborate the lung cancer biomarker proteins. 100 lung cancer patients and 50 age matched healthy controls were included in this study following exclusion and inclusion criteria and differentially expressed protein spots resulting from two dimensional serum profiling were excised, in-gel digested and analyzed by Maldi-Tof-Tof technique coupled with Mascot database search. A 28.061 kDa protein Apolipoprotein- A1 with isoelectric point of 5.27, identified at peptide mass tolerance of 149ppm, was investigated to be up regulated in squamous cell lung carcinoma cases compared to other types of lung cancer and healthy controls. Significant score of 117 and peptide sequence coverage of 56% authenticated the results of peptide mass fingerprinting and electro-elusion was performed to raise primary antisera in response to human Apolipoprotein- A1 to validate the proposed findings. Western blotting outcomes further validated the suggestion that Apolipoprotein –A1 is overexpressed in squamous lung carcinoma, leading to the useful diagnostic pathway establishment on clinical basis.